AptarGroup, Inc.

ATR Healthcare Medical Instruments & Supplies

AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024. In the quarter to June 2026, revenue grew 6.26%, EPS fell 18.3%, free cash flow fell 23.1% and total debt rose 66.4%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten.

124.51 0.25 +0.20%
Market cap
$7.9B
P/E
22.2×
Fwd P/E
21.0×
Dividend yield
1.54%
F-score
5/9
Altman Z
3.78
Beneish M
−2.48
Dividend safety
92/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
22.36 21.32 20.43 21.05

+8 more quarters

P/S ratio
2.03 2.08 2.12 2.40
P/FCF ratio
25.33 24.56 26.90 28.45
P/Operating CF
76.99 68.00 43.65 49.45
P/B ratio
3.01 3.05 2.99 3.15
EV/Sales
2.32 2.38 2.41 2.65
EV/EBITDA
11.65 11.62 11.53 12.25
EV/FCF
29.05 28.02 30.50 31.48
Current Ratio
1.61 1.66 1.62 1.19
Net Debt/EBITDA
5.67 6.20 5.87 4.41
Debt/Equity
0.52 0.52 0.55 0.43
Earnings Yield
4.47% 4.69% 4.90% 4.75%
Free Cash Flow Yield
3.95% 4.07% 3.72% 3.51%
Free Cash Flow per Share
0.74 0.84 1.48 1.77
Book value per Share
41.59 41.34 40.86 42.42
Free Cash Flow
46.93 54.03 97.60 116.02
EV/EBIT
19.14 18.60 18.14 18.88
Other line items

Show all line items

Columns are period end dates